In addition, infections with the herpes zoster virus occur frequently among patients treated with certain antimyeloma drugs, especially the proteasome inhibitors (bortezomib, carfilzomib, ixazomib) and the monoclonal antibodies (daratumumab, isatuximab, elotuzumab).